摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-氨基-2-硝基-苯甲酸甲酯 | 35998-96-0

中文名称
5-氨基-2-硝基-苯甲酸甲酯
中文别名
2-硝基-5-氨基苯甲酸甲酯
英文名称
methyl 5-amino-2-nitrobenzoate
英文别名
——
5-氨基-2-硝基-苯甲酸甲酯化学式
CAS
35998-96-0
化学式
C8H8N2O4
mdl
——
分子量
196.163
InChiKey
HBQRFDGMJZUGQV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    98-100 °C
  • 沸点:
    394.5±22.0 °C(Predicted)
  • 密度:
    1.386±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1
  • 重原子数:
    14
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.12
  • 拓扑面积:
    98.1
  • 氢给体数:
    1
  • 氢受体数:
    5

安全信息

  • 海关编码:
    2922499990
  • 危险标志:
    GHS07
  • 危险性描述:
    H302
  • 危险性防范说明:
    P280,P305+P351+P338
  • 储存条件:
    2-8°C

SDS

SDS:e55a290b4d7e8dfc2352c27bf5bde938
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    参考文献:
    名称:
    Backbone-Rigidified Oligo(m-phenylene ethynylenes)
    摘要:
    Oligo(m-phenylene ethynylenes) (oligo(m-PE)) with backbones rigidified by intramolecular hydrogen bonds were found to fold into well-defined conformations. The localized intramolecular hydrogen bond involves a donor and an acceptor from two adjacent benzene rings, respectively, which enforces globally folded conformations on these oligomers. Oligomers with two to seven residues have been synthesized and characterized. The persistence of the intramolecular hydrogen bonds and the corresponding curved conformations were established by ab initio and molecular mechanics calculations, 1D and 2D H-1 NMR spectroscopy, and UV spectroscopy. Pentamer 5, hexamer 6, and heptamer 7 adopt well-defined helical conformations. Such a backbone-based conformational programming should lead to molecules whose conformations are resilient toward structural variation of the side groups. These m-PE oligomers have provided a new approach for achieving folded unnatural oligonners; under conditions that are otherwise unfavorable for previously described, solvent-driven folding of m-PE foldamers. Stably folded structures based on the design principle described here can be developed and may find important applications.
    DOI:
    10.1021/ja039416d
  • 作为产物:
    描述:
    5-Azido-2-nitro-benzoic acid methyl ester 在 sodium tetrahydroborate 、 十六烷基三甲基溴化铵 、 cobalt(II) chloride 作用下, 以 为溶剂, 反应 0.33h, 以92%的产率得到5-氨基-2-硝基-苯甲酸甲酯
    参考文献:
    名称:
    氯化钴(II)催化化学选择性硼氢化钠还原水中叠氮化物
    摘要:
    将叠氮化物还原为胺和酰胺是在催化非均相条件下使用 NaBH4/CoCl2·6 H2O 在 25 °C 的单一水中进行的。广谱叠氮化物在短时间内被还原,化学选择性高产率和纯度。
    DOI:
    10.1055/s-2000-6389
点击查看最新优质反应信息

文献信息

  • HETEROCYCLIC ANTIVIRAL COMPOUNDS
    申请人:Chin Elbert
    公开号:US20100297073A1
    公开(公告)日:2010-11-25
    Compounds having the formula I wherein wherein R 1 , R 2 , R 3b , R 4a , R 4b , R 4c and as defined herein are Hepatitis C virus NS5b polymerase inhibitors. Also disclosed are compositions and methods for treating an HCV infection and inhibiting HCV replication.
    具有公式I的化合物,其中R1、R2、R3b、R4a、R4b、R4c如本文所述定义,是丙型肝炎病毒NS5b聚合酶抑制剂。同时公开了用于治疗HCV感染和抑制HCV复制的组合物和方法。
  • [EN] TREATMENT OF CHAGAS DISEASE<br/>[FR] TRAITEMENT DE LA MALADIE DE CHAGAS
    申请人:UNIV DUNDEE
    公开号:WO2015189595A1
    公开(公告)日:2015-12-17
    The invention provides compounds of the formula: wherein L1 and L2 are independently selected from O and S; R1 is C3-C6straight or branched alkyl, C3-C7cycloalkyl, C5-C7cycloalkenyl, adamantly, phenyl or saturated heterocyclyl, any of which being optionally substituted; R2 is H, methyl or ethyl; R5 is NRxCORy, NRxRy, CH2COCH3, CH2C≡N, or a 5- or 6-membered heteroaryl group which is optionally substituted; X, Y and Z are independently N or CH; Rx is independently H or C1-C4alkyl; Ry is independently H, CrC4alkyl, phenyl or benzyl, either of which is optionally substituted; n is 0-3; salts, hydrates and N-oxides, wherein the optional substituents are further defined in the claims. The compounds have utility in the prophylaxis or treatment of trypanosomal diseases, such as T. cruzi (Chagas disease).
    该发明提供了以下式的化合物:其中L1和L2分别选自O和S;R1为C3-C6直链或支链烷基,C3-C7环烷基,C5-C7环烯基,脱氢胆固醇,苯基或饱和杂环烷基,其中任一可选择地被取代;R2为H,甲基或乙基;R5为NRxCORy,NRxRy,CH2COCH3,CH2C≡N,或者是可选择地被取代的5-或6-成员杂芳基团;X、Y和Z分别为N或CH;Rx分别为H或C1-C4烷基;Ry分别为H,CrC4烷基,苯基或苄基,其中任一可选择地被取代;n为0-3;盐、合物和N-氧化物,其中可选择的取代基在权利要求中进一步定义。这些化合物在预防或治疗锥虫病等锥虫病方面具有用途。
  • Nucleophilic Reaction upon Electron-Deficient Pyridone Derivatives. XIII. Regioselective Synthesis of 2-Substituted 3-Nitropyridines by One-Pot Reaction of Either 4- or 6-Substituted 1-Methyl-3,5-dinitro-2-pyridones with Ketones and Ammonia
    作者:Yasuo Tohda、Tohru Kawahara、Miyuki Eiraku、Keita Tani、Nagatoshi Nisiwaki、Masahiro Ariga
    DOI:10.1246/bcsj.67.2176
    日期:1994.8
    A one-pot synthesis of 2-substituted 3-nitropyridines was developed by a ring transformation of 6- or 4-substituted 1-methyl-3,5-dinitro-2-pyridones (2 or 3) with ammonia and enamines derived from ketones. Some intermediates having a 2,6-diazabicyclo[3.3.1]nonane skeleton were isolated from reactions of 3. The ring transformation proceeds via an addition-addition-elimination-elimination mechanism.
    2-取代 3-硝基吡啶的一锅合成是通过 6-或 4-取代的 1-甲基-3,5-二硝基-2-吡啶酮(2 或 3)与和酮衍生的烯胺的环转化而开发的. 一些具有2,6-二氮杂双环[3.3.1]壬烷骨架的中间体从3的反应中分离出来。环转化通过加成-加成-消除-消除机制进行。形成了很少的竞争性异构副产物,即 4-取代的 3-硝基吡啶4-硝基苯胺。2 种底物均表现出良好的反应性,但具有吸电子取代基的 3 种底物反应性和选择性较差。1,4,6-三甲基-3,5-二硝基-2-吡啶酮没有得到任何产物。
  • Solid-phase synthesis of 2-cyanoquinazolin-4(3H)-one and 2,3-dihydrooxazolo[2,3-b]quinazolin-5-one derivatives utilizing resin-bound anthranilic acid derivatives
    作者:Moon-Kook Jeon、Dong-Su Kim、Hyun Ju La、Deok-Chan Ha、Young-Dae Gong
    DOI:10.1016/j.tetlet.2005.09.015
    日期:2005.10
    We were able to obtain 2-cyanoquinazolin-4(3H)-ones 11 in 35–60% four-step overall isolated yields and 2,3-dihydrooxazolo[2,3-b]quinazolin-5-ones 12 in 20–71% four-step overall isolated yields utilizing polymer-bound anthranilic acid derivatives 1, and 6-amino-2-cyanoquinazolin-4(3H)-ones 19 in 30–44% six-step overall isolated yields making use of anthranilic acid derivative resin 2 via dithiazole
    我们能够以35–60%的四步总分离产率获得2-cyanoquinazolin-4(3 H)-ones 11和20–20中获得2,3-dihydrooxazolo [2,3- b ] quinazolin-5-ones 12利用邻氨基苯甲酸生物1和6-基-2-喹唑啉-4(3 H)-ones 19的四步总分离产率为71%,而邻氨基苯甲酸的30-44%六步总分离产率为71%经由二噻唑树脂10和17的衍生树脂2。通过单珠ATR-FTIR光谱法监测固相反应。
  • Synthesis of Aryl Azides via Post-Cleavage Modification of Polymer-Bound Triazenes
    作者:Stefan Bräse、Frank Avemaria、Viktor Zimmermann
    DOI:10.1055/s-2004-82298
    日期:——
    Starting from immobilized arenes on the triazene T1 linker resin, cleavage was achieved by trifluoroacetic acid in the presence of trimethylsilyl azide to obtain aryl azides in good yields and excellent purities. A novel cleavage protocol has been introduced and analytical and preparative applications have been presented.
    从固定在三氮烯 T1 连接树脂上的芳烃开始,在三甲基甲硅烷叠氮化物存在下通过三氟乙酸实现裂解,以良好的产率和优异的纯度获得芳基叠氮化物。引入了一种新的裂解方案,并提出了分析和制备应用。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫